HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

7- ((4- (pyridin- 2- ylamino)- butyrylamino)- methyl)- 6,9- dihydro- 5H- benzocyclohepten- 5- yl- acetic acid hydrochloride

structure in first source

Also Known As:

S 34961

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cycloheptanes
        7-((4-(pyridin-2-ylamino)-butyrylamino)-methyl)-6,9-dihydro-5H-benzocyclohepten-5-yl-acetic acid hydrochloride: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 7-((4-(pyridin-2-ylamino)-butyrylamino)-methyl)-6,9-dihydro-5H-benzocyclohepten-5-yl-acetic acid hydrochloride: 1

Experts

1.	Burbridge, Mike F: 1 article (06/2003)
2.	Casara, Patrick J: 1 article (06/2003)
3.	Hickman, John A: 1 article (06/2003)
4.	Perron-Sierra, Françoise: 1 article (06/2003)
5.	Tucker, Gordon C: 1 article (06/2003)
6.	Venot, Virginie: 1 article (06/2003)

Related Diseases

1.	Neoplasms (Cancer) 06/01/2003 - "Together, these results suggested that although treatment with S 34961 has no effect on survival per se, it may reduce the survival threshold of the tumor cells, with Bak in an activated state. "
2.	Carcinoma (Carcinomatosis) 06/01/2003 - "We used S 34961, a novel small molecule alphav integrin antagonist, to investigate the role of integrin-signaling in the survival of populations of quiescent human HT-29 and HCT 116 colon carcinoma cells. "

Related Drugs and Biologics

1.	Integrin alphaV
2.	Integrins